The Institute of Cancer Research/LinkedIn
May 30, 2025, 07:10
The Institute of Cancer Research Shared Blood Cancer Patient Story
The Institute of Cancer Research shared a post on LinkedIn:
“‘Research into blood cancer is so very, very important’
When Karin, 65, was diagnosed with acute myeloid leukaemia (AML), a type of blood cancer, she was told that without treatment, she had just a week left to live.
Thanks to chemotherapy and a clinical trial, where she was given a targeted treatment that she took for two years, she has been in remission ever since. Today, more than 20 years after her diagnosis, she says she is living life to the full.
At the ICR, our world-class scientists are leading the charge in developing innovative approaches to outsmart blood cancer, including AML.
Please make a regular gift today to support the vital work our scientists are doing and to help more people survive blood cancer.
Please donate today.”
Proceed to the video attached to the post.
Read Our Article about Immunotherapy for Blood Cancer.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 12, 2025, 14:38
Jul 12, 2025, 14:29
Jul 12, 2025, 14:27
Jul 12, 2025, 14:23
Jul 12, 2025, 14:16
Jul 12, 2025, 13:02